Selvita S.A. Net Assets
Selvita S.A. net assets. Based on the latest financial reports, Selvita S.A. (SLV) has net assets worth zł317.10 Million PLN (≈ $87.27 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł584.11 Million ≈ $160.76 Million USD) and total liabilities (zł267.02 Million ≈ $73.49 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Selvita S.A. balance sheet independence to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł317.10 Million |
| % of Total Assets | 54.29% |
| Annual Growth Rate | 21.24% |
| 5-Year Change | 56.52% |
| 10-Year Change | 477.49% |
| Growth Volatility | 65.88 |
Net Assets of Selvita S.A. (2015–2025)
Net assets of Selvita S.A. from 2015 to 2025. This chart illustrates how Selvita S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore SLV net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Net Assets for Selvita S.A. (2015–2025)
The table below shows the annual net assets of Selvita S.A. from 2015 to 2025. For live market cap and overall valuation, see Selvita S.A. (SLV) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł321.73 Million ≈ $88.54 Million |
-0.05% |
| 2024-12-31 | zł321.88 Million ≈ $88.59 Million |
-1.59% |
| 2023-12-31 | zł327.07 Million ≈ $90.01 Million |
+19.74% |
| 2022-12-31 | zł273.16 Million ≈ $75.18 Million |
+32.89% |
| 2021-12-31 | zł205.55 Million ≈ $56.57 Million |
+34.65% |
| 2020-12-31 | zł152.66 Million ≈ $42.01 Million |
+220.33% |
| 2019-12-31 | zł47.66 Million ≈ $13.12 Million |
-3.11% |
| 2018-12-31 | zł49.19 Million ≈ $13.54 Million |
+31.73% |
| 2017-12-31 | zł37.34 Million ≈ $10.28 Million |
-32.97% |
| 2016-12-31 | zł55.71 Million ≈ $15.33 Million |
+18.84% |
| 2015-12-31 | zł46.88 Million ≈ $12.90 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Selvita S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3734.9% over the analyzed period, indicating profitable operations and earnings retention.
Selvita S.A. Net Assets Breakdown (December 2025)
Selvita S.A. net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł133.41 Million | 41.47% |
| Common Stock | zł14.68 Million | 4.56% |
| Other Comprehensive Income | zł87.18 Million | 27.10% |
| Other Components | zł86.45 Million | 26.87% |
| Total Equity | zł321.73 Million | 100.00% |
Selvita S.A. Competitors by Market Cap
The table below lists competitors of Selvita S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tainan Enterprises Co Ltd
TW:1473
|
$86.80 Million |
|
Apollo Silver Corp
V:APGO
|
$86.84 Million |
|
Vittia Fertilizantes
SA:VITT3
|
$86.84 Million |
|
Bioton S.A.
WAR:BIO
|
$86.84 Million |
|
Insumos Agroquimicos SA
BA:INAG
|
$86.74 Million |
|
Trivago NV
NASDAQ:TRVG
|
$86.72 Million |
|
Bien Sparebank ASA
OL:BIEN
|
$86.67 Million |
|
Sunrise Realty Trust, Inc.
NASDAQ:SUNS
|
$86.64 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Selvita S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 321,877,000 to 321,730,000, a change of -147,000 (-0.0%).
- Net income of 813,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 959,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł813.00K | +0.25% |
| Other Comprehensive Income | zł-959.00K | -0.3% |
| Other Changes | zł-1.00K | -0.0% |
| Total Change | zł- | -0.05% |
Book Value vs Market Value Analysis
This analysis compares Selvita S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.98x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.95x to 0.98x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | zł2.89 | zł17.18 | x |
| 2016-12-31 | zł3.44 | zł17.18 | x |
| 2017-12-31 | zł2.21 | zł17.18 | x |
| 2018-12-31 | zł2.87 | zł17.18 | x |
| 2019-12-31 | zł2.77 | zł17.18 | x |
| 2020-12-31 | zł8.56 | zł17.18 | x |
| 2021-12-31 | zł10.73 | zł17.18 | x |
| 2022-12-31 | zł14.28 | zł17.18 | x |
| 2023-12-31 | zł17.82 | zł17.18 | x |
| 2024-12-31 | zł17.54 | zł17.18 | x |
| 2025-12-31 | zł17.53 | zł17.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Selvita S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.22%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.86x
- Recent ROE (0.25%) is below the historical average (10.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 13.50% | 15.28% | 0.63x | 1.40x | zł1.63 Million |
| 2016 | 4.91% | 5.65% | 0.54x | 1.61x | zł-2.82 Million |
| 2017 | 11.01% | 7.19% | 1.14x | 1.34x | zł361.58K |
| 2018 | 22.70% | 14.85% | 0.97x | 1.57x | zł5.87 Million |
| 2019 | 12.49% | 18.14% | 0.33x | 2.06x | zł1.10 Million |
| 2020 | 12.22% | 13.10% | 0.63x | 1.49x | zł3.27 Million |
| 2021 | 7.57% | 4.79% | 0.67x | 2.37x | zł-4.79 Million |
| 2022 | 11.56% | 8.40% | 0.62x | 2.23x | zł4.09 Million |
| 2023 | 21.36% | 20.15% | 0.54x | 1.95x | zł37.17 Million |
| 2024 | -1.89% | -1.78% | 0.53x | 1.99x | zł-38.29 Million |
| 2025 | 0.25% | 0.22% | 0.61x | 1.86x | zł-31.36 Million |
Industry Comparison
This section compares Selvita S.A.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $49,941,692
- Average return on equity (ROE) among peers: -2.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Selvita S.A. (SLV) | zł317.10 Million | 13.50% | 0.84x | $86.77 Million |
| Biomaxima (BMX) | $7.85 Million | 12.73% | 0.67x | $11.25 Million |
| Scope Fluidics SA (SCP) | $33.09 Million | -22.54% | 0.25x | $117.33 Million |
| Voxel S.A. (VOX) | $108.89 Million | 2.77% | 0.98x | $453.80 Million |
About Selvita S.A.
Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libr… Read more